3 completed, 2 unknown, 1 enrolling by invitation, 1 recruiting. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 3, Unknown 2, Enrolling by invitation 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Sulodexide: new trials by email Literature Review of Sulodexide trials Research Report on Sulodexide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sulodexide in Controlling the Recurrence of Psoriasis Sulodexide, Placebo - Psoriasis (PsO), Randomised Controlled Trial | Phase 3 | Enrolling by invitation | Xijing Hospital | 160 | 2025-04-20 | 2025-05-21 |
| Endothelial Protection in Post COVID-19 Patients With Sulodexide Sulodexide - Post COVID-19, Endothelial Dysfunction | Phase 3 | Completed | Centro Medico del Noroeste | 206 | 2023-06-01 | 2024-08-09 |
| Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) Sulodexide, Sulodexide and placebo, Placebo - Venous Thromboembolism, Anticoagulant | Phase 3 | Recruiting | Arianna Anticoagulazione Foundation | 1455 | 2020-12-21 | 2024-07-31 |
| Suloexide in the Treatment of Early Stages of COVID-19 Sulodexide, Placebo - Covid19 | Phase 2 / Phase 3 | Completed | Clinedem | 243 | 2020-06-05 | 2020-09-09 |
| Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone Sulodexide, Statin, Antiplatelet Agents - Peripheral Arterial Obstructive Disease | Phase 3 | Unknown | Alfa Wassermann Tunisia | 156 | 2019-01-31 | 2019-12-02 |
| The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney Disease Sulodexide, placebo capsules - Chronic Kidney Disease | Phase 3 | Unknown | Corbridge Group Philippines, Inc. | 1508 | 2009-11-01 | 2009-10-30 |
| Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong sulodexide - Diabetic Nephropathy | Phase 3 | Terminated | Keryx Biopharmaceuticals | 200 | 2007-04-01 | 2017-03-03 |
| Effect of Sulodexide in Early Diabetic Nephropathy Sulodexide, Placebo - Diabetic Nephropathy | Phase 3 | Completed | Keryx Biopharmaceuticals | 1056 | 2005-08-01 | 2018-03-23 |
Diabetes Mellitus (3) · Albuminuria (2) · Diabetic Nephropathies (2) · COVID-19 (1) · Diabetes Mellitus, Type 2 (1) · Kidney Diseases (1) · Proteinuria (1) · Psoriasis (1) · Renal Insufficiency, Chronic (1) · Thrombosis (1) · Venous Thromboembolism (1)
Keryx Biopharmaceuticals (2) · Alfa Wassermann Tunisia (1) · Arianna Anticoagulazione Foundation (1) · Centro Medico del Noroeste (1) · Clinedem (1) · Corbridge Group Philippines, Inc. (1) · Xijing Hospital (1)
Australia (2) · Mexico (2) · China (1) · Italy (1) · Netherlands (1) · Philippines (1) · Tunisia (1) · United States (1)
Alejandro J Gonzalez-Ochoa, MD (1) · Anne Reutens, MD (1) · Corrado Lodigiani, MD,PhD (1) · Edmund J Lewis, M.D. (1) · Gang Wang (1) · Imed Frikha, MD (1) · Itamar Raz, M.D. (1) · Robert Atkins, MD (1) · Robert C Atkins, M.D. (1)
PMID 21872376, PMID 31595056, PMID 31899186, PMID 32365242, PMID 32427307, PMID 32451933, PMID 32888954, PMID 33812489, PMID 33995668, PMID 35244208, PMID 35601055, PMID 36917196
2019 (1)